Ethanol Prevents Microvascular Dysfunction

乙醇预防微血管功能障碍

基本信息

  • 批准号:
    7630624
  • 负责人:
  • 金额:
    $ 32.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-15 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ethanol consumption at low to moderate levels protects the heart and vasculature from the deleterious effects of ischemia and reperfusion (I/R). Our recent work indicates that antecedent ethanol ingestion provokes the development of an anti-inflammatory phenotype in postcapillary venules such that these microvessels fail to support leukocyte/endothelial cell adhesive interactions during I/R. Surprisingly, AMP-activated kinase (AMPK) plays a necessary role in initiating this adaptive transformation to a protected phenotype in postcapillary venules. However, it is not clear how this enzyme, best known for its role as a metabolic master switch, is involved in transducing signals elicited by ethanol to effect the acquisition of tolerance to I/R in the microcirculation. Our overall hypothesis is that ethanol-induced, AMPK-dependent eNOS activation serves as an important initiating factor to trigger a cascade of signaling events that ultimately act to promote the expression of cytochrome P450 epoxygenases (CYP), which serve as an important effector of the beneficial microvascular actions of ethanol by catalyzing the formation of reaction products which exhibit powerful anti-adhesive and antioxidant properties. To address this postulate, we propose to determine whether: (1) ethanol-induced AMPK activation initiates the development of an anti-inflammatory phenotype by stimulating the formation of eNOS-derived NO; (2) NO-induced release of calcitonin gene-related peptide (CGRP) plays an essential role in the acquisition of tolerance to ischemia that is evoked by antecedent ethanol consumption; (3) the cystic fibrosis transmembrane regulator (CFTR) serves as an obligatory downstream signaling element that participates in inaugurating the development of the protected phenotype precipitated by ethanol-induced AMPK activation; and (4) ethanol-induced, AMPK-triggered increases in CYP activity during I/R prevents postischemic leukocyte adhesion in postcapillary venules by abrogating P-selectin expression. Intravital microscopic approaches will be used to quantify leukocyte rolling and adhesion in wild-type control mice and in mutant mice lacking AMPK, eNOS, CGRP, or CFTR. The influence of ethanol on l/R-induced adhesion molecule expression, AMPK and eNOS activity, CGRP release, and CYP protein expression and activity will also be investigated. Collectively, these aims address novel mechanisms whereby antecedent ethanol ingestion induces the development of an anti-inflammatory phenotype in postcapillary venules. This work will identify new links between ethanol-induced, AMPK-dependent, eNOS-derived NO formation as essential triggering elements, CGRP release and CFTR function as obligatory downstream mediators, and increased CYP activity as a major effector in the acquisition of tolerance to I/R by antecedent ethanol ingestion.
描述(由申请人提供):低至中等水平的乙醇消耗可保护心脏和血管系统免受缺血和再灌注(I/R)的有害影响。我们最近的工作表明,先前的乙醇摄入会引起毛细血管后微静脉中抗炎表型的发展,使得这些微血管在I/R期间无法支持白细胞/内皮细胞粘附相互作用。令人惊讶的是,AMP激活激酶(AMPK)在启动这种适应性转化为受保护的表型在毛细血管后微静脉中起着必要的作用。然而,目前尚不清楚这种酶,最为人所知的作用作为一个代谢的主开关,是如何参与由乙醇引起的信号转导,以影响获得耐受性的微循环中的I/R。我们的总体假设是,乙醇诱导的AMPK依赖性eNOS活化作为一个重要的起始因子,触发一系列信号传导事件,最终促进细胞色素P450环氧合酶(CYP 450 epoxygenases,CYP 450 epoxygenases)的表达,其通过催化反应产物的形成,表现出强大的抗粘附和抗氧化特性,作为乙醇有益微血管作用的重要效应物。为了解决这一假设,我们打算确定:(1)乙醇诱导的AMPK激活是否通过刺激eNOS衍生的NO的形成启动抗炎表型的发展;(2)NO诱导的降钙素基因相关肽(CGRP)的释放在获得对缺血的耐受中起重要作用,这是由先前的乙醇消耗引起的;(3)囊性纤维化跨膜调节因子(CFTR)作为一种必需的下游信号元件,参与启动由乙醇诱导的AMPK活化沉淀的受保护表型的发展;(4)乙醇诱导的AMPK触发的I/R过程中血小板活性的增加通过消除P-选择素的表达来防止缺血后毛细血管后微静脉中白细胞的粘附。将使用活体显微镜方法定量野生型对照小鼠和缺乏AMPK、eNOS、CGRP或CFTR的突变小鼠中的白细胞滚动和粘附。还将研究乙醇对I/R诱导的粘附分子表达、AMPK和eNOS活性、CGRP释放以及CGRP蛋白表达和活性的影响。总的来说,这些目标解决了新的机制,即先行乙醇摄入诱导发展的抗炎表型在毛细血管后小静脉。这项工作将确定乙醇诱导的,AMPK依赖的,eNOS衍生的NO形成作为必要的触发元件,CGRP释放和CFTR功能作为强制性下游介质,并增加作为一个主要效应器的活性增加的β-内酰胺酶在收购耐受性的I/R由先行乙醇摄入之间的新的联系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RONALD JOHN KORTHUIS其他文献

RONALD JOHN KORTHUIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RONALD JOHN KORTHUIS', 18)}}的其他基金

Daily Moderate Ethanol Ingestion Attenuates Postischemic Microvascular Dysfunctio
每日适量摄入乙醇可减轻缺血后微血管功能障碍
  • 批准号:
    8757257
  • 财政年份:
    2015
  • 资助金额:
    $ 32.38万
  • 项目类别:
Daily Moderate Ethanol Ingestion Attenuates Postischemic Microvascular Dysfunctio
每日适量摄入乙醇可减轻缺血后微血管功能障碍
  • 批准号:
    9017894
  • 财政年份:
    2015
  • 资助金额:
    $ 32.38万
  • 项目类别:
Microvascular Dysfunction: Impact Ischemia-Reperfusion Vascular Cell Interaction
微血管功能障碍:影响缺血再灌注血管细胞相互作用
  • 批准号:
    7918618
  • 财政年份:
    2010
  • 资助金额:
    $ 32.38万
  • 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
  • 批准号:
    7340482
  • 财政年份:
    2006
  • 资助金额:
    $ 32.38万
  • 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
  • 批准号:
    7197453
  • 财政年份:
    2006
  • 资助金额:
    $ 32.38万
  • 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
  • 批准号:
    7569377
  • 财政年份:
    2006
  • 资助金额:
    $ 32.38万
  • 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
  • 批准号:
    7752528
  • 财政年份:
    2006
  • 资助金额:
    $ 32.38万
  • 项目类别:
Ethanol Prevents Microvascular Dysfunction
乙醇预防微血管功能障碍
  • 批准号:
    7245864
  • 财政年份:
    2006
  • 资助金额:
    $ 32.38万
  • 项目类别:
Ethanol Prevents Microvascular Dysfunction
乙醇预防微血管功能障碍
  • 批准号:
    7036114
  • 财政年份:
    2006
  • 资助金额:
    $ 32.38万
  • 项目类别:
Ethanol Prevents Microvascular Dysfunction
乙醇预防微血管功能障碍
  • 批准号:
    7433302
  • 财政年份:
    2006
  • 资助金额:
    $ 32.38万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 32.38万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 32.38万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 32.38万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了